BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumada T, Toyoda H, Yasuda S, Tada T, Ogawa S, Takeshima K, Tanaka J, Chayama K, Johnson PJ. Impact of the introduction of direct-acting anti-viral drugs on hepatocarcinogenesis: a prospective serial follow-up MRI study. Aliment Pharmacol Ther 2020;52:359-70. [PMID: 32519782 DOI: 10.1111/apt.15825] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Ito T. Editorial: impact of the introduction of direct-acting anti-viral drugs on hepatocarcinogenesis-a prospective serial follow-up MRI study. Aliment Pharmacol Ther 2020;52:735-6. [PMID: 32886380 DOI: 10.1111/apt.15911] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Lin BQ, Zhang WB, Zhao J, Zhou XH, Li YJ, Deng J, Zhao Q, Fu G, Xie CM, Xu YK, Feng GK. An Optimized Integrin α6-Targeted Magnetic Resonance Probe for Molecular Imaging of Hepatocellular Carcinoma in Mice. J Hepatocell Carcinoma 2021;8:645-56. [PMID: 34235103 DOI: 10.2147/JHC.S312921] [Reference Citation Analysis]
3 Kumada T, Toyoda H, Yasuda S, Sone Y, Ogawa S, Takeshima K, Tada T, Ito T, Sumida Y, Tanaka J. Prediction of Hepatocellular Carcinoma by Liver Stiffness Measurements Using Magnetic Resonance Elastography After Eradicating Hepatitis C Virus. Clin Transl Gastroenterol 2021;12:e00337. [PMID: 33888672 DOI: 10.14309/ctg.0000000000000337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kumada T. Editorial: impact of the introduction of direct-acting antiviral drugs on hepatocarcinogenesis-a prospective serial follow-up MRI study. Author's reply. Aliment Pharmacol Ther 2020;52:737-8. [PMID: 32886360 DOI: 10.1111/apt.15939] [Reference Citation Analysis]
5 Miki D, Akita T, Kurisu A, Kawaoka T, Nakajima T, Hige S, Karino Y, Toyoda H, Kumada T, Tsuge M, Hiramatsu A, Imamura M, Aikata H, Hayes CN, Honda K, Seike M, Akuta N, Kobayashi M, Kumada H, Tanaka J, Chayama K. PNPLA3 and HLA-DQB1 polymorphisms are associated with hepatocellular carcinoma after hepatitis C virus eradication. J Gastroenterol 2020;55:1162-70. [PMID: 33057914 DOI: 10.1007/s00535-020-01731-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Toyoda H, Yasuda S, Shiota S, Kumada T. Long-term persistence of hepatocarcinogenic potential of a non-hypervascular hypointense nodule on EOB-MRI after the eradication of hepatitis C virus. Hepatol Res 2022;52:128-32. [PMID: 34472681 DOI: 10.1111/hepr.13707] [Reference Citation Analysis]